Transient myelofibrosis with autoimmune pancytopenia: a case report

Eur J Pediatr. 2009 Aug;168(8):1003-6. doi: 10.1007/s00431-008-0867-y. Epub 2008 Nov 6.

Abstract

Introduction: Myelofibrosis associated with myelodysplasia is thought to herald poor prognosis in myelodysplastic syndrome (MDS).

Case report: A 7-month-old boy presented with fever (39 degrees C), pancytopenia, and slight hepatosplenomegaly (3 and 2 cm, respectively). Bone marrow showed hypercellularity, hyperplasia of erythroblasts, and also myelofibrosis. IgG was 1,136 mg/dL, IgA was 131 mg/dL, and IgM was 89 mg/dL. Antinuclear and antineutrophil antibodies, red-blood-cell-associated IgG, antiplatelet antibodies, and Coombs test were positive. Karyotype was 46XY. No viral cause was evidenced. Mild myelodysplasia was revealed two months later, but was insufficient to support a diagnosis of MDS. The boy was treated with transfusion of packed cells, prednisolone 2 mg/kg/day for 3 weeks associated with intravenous gammaglobulin 400 mg/kg/day for 5 days. Direct Coombs remained positive 1 month after treatment for 5 months, myelofibrosis persisted for 3 months, and neutropenia for 21 months. After 3-year follow-up, hematological data were normal without any therapeutic intervention.

Conclusion: Myelofibrosis associated with mild myelodysplasia and pancytopenia can have a benign evolution in infants and young children.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Autoimmune Diseases* / pathology
  • Bone Marrow / pathology
  • Diagnosis, Differential
  • Humans
  • Infant
  • Japan
  • Male
  • Myeloproliferative Disorders / diagnosis
  • Pancytopenia* / pathology
  • Primary Myelofibrosis* / pathology
  • Remission, Spontaneous